HomeCompareBFAGY vs SBUX

BFAGY vs SBUX: Dividend Comparison 2026

BFAGY yields 80.65% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BFAGY wins by $1.55M in total portfolio value
10 years
BFAGY
BFAGY
● Live price
80.65%
Share price
$2.48
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.71M
Annual income
$496,450.73
Full BFAGY calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — BFAGY vs SBUX

📍 BFAGY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBFAGYSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BFAGY + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BFAGY pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BFAGY
Annual income on $10K today (after 15% tax)
$6,854.84/yr
After 10yr DRIP, annual income (after tax)
$421,983.12/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, BFAGY beats the other by $366,019.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BFAGY + SBUX for your $10,000?

BFAGY: 50%SBUX: 50%
100% SBUX50/50100% BFAGY
Portfolio after 10yr
$932.5K
Annual income
$281,145.43/yr
Blended yield
30.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

BFAGY
No analyst data
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BFAGY buys
0
SBUX buys
0
No recent congressional trades found for BFAGY or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBFAGYSBUX
Forward yield80.65%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$1.71M$157.5K
Annual income after 10y$496,450.73$65,840.13
Total dividends collected$1.49M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: BFAGY vs SBUX ($10,000, DRIP)

YearBFAGY PortfolioBFAGY Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$18,765$8,064.52$11,107$407.21+$7.7KBFAGY
2$34,221$14,142.69$12,512$626.87+$21.7KBFAGY
3$60,721$24,104.60$14,366$978.69+$46.4KBFAGY
4$104,944$39,972.77$16,929$1,557.50+$88.0KBFAGY
5$176,856$64,565.54$20,658$2,543.80+$156.2KBFAGY
6$290,925$101,690.00$26,406$4,302.22+$264.5KBFAGY
7$467,626$156,335.44$35,877$7,622.00+$431.7KBFAGY
8$735,209$234,849.84$52,741$14,352.64+$682.5KBFAGY
9$1,131,753$345,079.47$85,676$29,243.03+$1.05MBFAGY
10$1,707,427$496,450.73$157,513$65,840.13+$1.55MBFAGY

BFAGY vs SBUX: Complete Analysis 2026

BFAGYStock

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Full BFAGY Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this BFAGY vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BFAGY vs SCHDBFAGY vs JEPIBFAGY vs OBFAGY vs KOBFAGY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.